Efficacy of Linco-Spectin medication on mycoplasma meleagridis airsacculitis in turkey poults.
The efficacy of Linco-Spectin (LS) water medication was determined against Mycoplasma meleagridis (MM) airsacculitis in turkey poults under controlled conditions. The poults were obtained from commercial flocks naturally infected with MM. Water medication was given for the first five days of life. In Georgia and Ohio, LS was given at 0, 1, 2, and 4 g per gallon of drinking water. In California and Minnesota, LS was administered at 0 and 2 g per gallon of drinking water. At three weeks old, the birds were weighed individually and examined serologically, culturally, and grossly for MM airsacculitis. LS at 2 g activity per gallon of drinking water was beneficial in controlling MM airsacculitis in all four trials.
D000284:Administration, Oral; D000400:Air Sacs; D000818:Animals; D008034:Lincomycin / Q000008:administration & dosage / Q000627:therapeutic use*; D009175:Mycoplasma Infections / Q000188:drug therapy / Q000662:veterinary*; D011201:Poultry Diseases / Q000188:drug therapy*; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000662:veterinary*; D000198:Spectinomycin / Q000008:administration & dosage / Q000627:therapeutic use*; D014422:Turkeys; D014867:Water
D014867:Water; D000198:Spectinomycin; D008034:Lincomycin